Rapamycin: Drug Repurposing in SARS-CoV-2 Infection

Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with enormous consequences for human health and the world economy. Remdesivir is the only drug in the world that has been approved for the treating of COVID-19. This drug, as well as vaccination, still has uncertain effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Patocka, Jiri, Kuca, Kamil, Oleksak, Patrik, Nepovimova, Eugenie, Valis, Martin, Novotny, Michal, Klimova, Blanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001969/
https://www.ncbi.nlm.nih.gov/pubmed/33807743
http://dx.doi.org/10.3390/ph14030217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001969/
https://www.ncbi.nlm.nih.gov/pubmed/33807743
http://dx.doi.org/10.3390/ph14030217

Ejemplares similares